7th Annual AMIA Invitational Health Policy Meeting December 12-13 ...

and writing for the Health Information & the Law website. Her interests include health
information technology related to health disparities and privacy of health information.
Megan Martin, BSN, RN is a Masters student in Nursing at the University of Illinois Chicago,
concentrating in Nursing Administration and Health Informatics. Megan currently works for
Advocate Medical Group as a Clinical Coordinator. She is a member of Sigma Theta Tau and the
American Medical Informatics Association.
Shawn Murphy, MD, PhD, developed and has directed the Research Patient Data Registry
(RPDR) for Partners Health Care System, beginning in 1999; this information resource allows
human studies investigators to access vast amounts of aggregate patient clinical data. Dr.
Murphy has served as director of the pharmacovigilance project for Partners since 2007 and
Medical Director Research Computing for Partners since 2008. He assumed all responsibility at
Partners for oversight of the research computing network which includes development and
support for genetics and genomics at the Partners Center for Personalized Genetic Medicine;
development and support of tissue sampling and banking; development and support of cluster
and other high performance computing; and the continued development and support of RPDR,
Informatics for Integrating Biology an d the Bedside, and the Pharmacovigilance platforms at
Partners.
Douglas Peddicord, PhD, is President of the Washington Health Strategies Group and provides
lobbying and government relations services to a variety of health-related organizations.
Following a career as a clinical psychologist, he came to Capitol Hill as an American Association
for the Advancement of Science (AAAS) Congressional Fellow in 1994. Having been involved
with health information policy issues – from privacy, interoperability and HIT implementation to
EHRs, PHRs and the evolution of a national health information infrastructure – ever since, Dr.
Peddicord has represented AMIA in Washington since 1997.
Gurvaneet Randhawa, MD, MPH, works in the Center for Outcomes and Evidence (COE) at the
Agency for Healthcare Research and Quality (AHRQ). He is the program officer on all AHRQ
grants that will build and enhance clinical electronic data infrastructure to collect and evaluate
prospective, patient-centered outcomes for comparative effectiveness research (CER) focusing
on AHRQ priority conditions and populations. These grants are part of four programs: scalable
distributed research networks, enhanced registries for quality improvement and CER,
PROSPECT, and Electronic Data Methods Forum (http://www.edm-forum.org). These projects
will develop electronic clinical infrastructure with the potential capability of performing several
functions: CER, quality improvement, disease surveillance and clinical decision support. Dr.
Randhawa also provides scientific direction to clinical genomics-related projects conducted by
different AHRQ programs. He is interested in research to improve capabilities of the existing
electronic clinical data infrastructure in order to clarify the added value of new diagnostics and
therapeutics. He has overseen the development of many Evidence-based Practice Center (EPC)
reports that systematically and comprehensively clarified the existing evidence on questions of
interest to different audiences, including the U.S. Preventive Services Task Force (USPSTF) and
the EGAPP working group. He is a past director of the USPSTF program. He has provided
programmatic guidance and oversight to the DARTNet project that focused on distributed
research in ambulatory care. Prior to joining AHRQ, Dr. Randhawa completed his Preventive
AMIA Invitational Health Policy Meeting 2012
Page 29 12/10/2012